This site is intended for health professionals only

Editor’s pick

Therapy brings blood disorder hope
Therapy brings blood disorder hope
MabThera improves adult leukaemia patient responses
MabThera improves adult leukaemia patient responses
Lacosamide helps patients with diabetic neuropathic pain
Lacosamide helps patients with diabetic neuropathic pain
Eisai to buy rival in $3.9bn deal
Eisai to buy rival in $3.9bn deal
Study boost for cancer drug success
Study boost for cancer drug success
Reckitt buys drug firm for £1.1bn
Reckitt buys drug firm for £1.1bn
Rivaroxaban “superior to enoxaparin for VTE”
Rivaroxaban “superior to enoxaparin for VTE”
GSK and Galapagos sign anti-infectives deal
GSK and Galapagos sign anti-infectives deal
Olmetec first ARB to suggest atherosclerosis regression
Olmetec first ARB to suggest atherosclerosis regression
Drug firm bought by beauty group
Drug firm bought by beauty group
Pharmion to present key haematology product data
Pharmion to present key haematology product data
Avastin rejected for breast cancer
Avastin rejected for breast cancer
1 … 231 232 233 234 235 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x